CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism.
CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism.
复制标题
DOI:
10.1136/jnnp-2016-315251
复制
发表时间:
2017-09
期刊:
影响因子:
--
通讯作者:
Vincent A
中科院分区:
文献类型:
--
作者:
Coutinho E;Jacobson L;Pedersen MG;Benros ME;Nørgaard-Pedersen B;Mortensen PB;Harrison PJ;Vincent A
Maternal autoantibodies to neuronal proteins may be one cause of neurodevelopmental disorders. This exploratory study used the Danish archived midgestational sera and their nationwide registers to search for antibodies to the N-methyl-D-aspartate receptor (NMDAR) and contactin-associated protein-like 2 (CASPR2) in maternal sera, and to relate them to subsequent psychiatric diagnoses in the woman or her child. In a sample of 192 women, there was no association between antibody status and subsequent psychosis in the mothers. However, NMDAR antibodies (n=4) or CASPR2 antibodies (n=1) were identified in 5/11 (45.5%) women whose children were given a diagnosis of mild or unspecified mental retardation or disorders of psychological and motor development (collectively abbreviated as mental retardation and/or disorders of psychological development (MR/DPD)) compared with 9/176 (5.1%) of the remaining mother (p<0.001). These findings were followed up in a specifically selected cohort, in which CASPR2 antibodies were detected in 7/171 (4.1%) mothers of MR/DPD progeny, compared with only 1/171 (0.6%) control mother (p=0.067). The combined sample showed a significantly higher frequency of CASPR2 antibodies in mothers of MD/DPD children (p=0.01). These autoantibodies were not increased in mothers of children with autistic spectrum disorder. These findings complement the known roles of CASPR2 in brain development, and warrant further epidemiological and experimental studies to clarify the role of CASPR2 and possibly other antibodies in neurodevelopmental disorders.
登录
查看更多内容
DOI:
10.1093/brain/awq113
发表时间:
2010-06
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Irani SR;Bera K;Waters P;Zuliani L;Maxwell S;Zandi MS;Friese MA;Galea I;Kullmann DM;Beeson D;Lang B;Bien CG;Vincent A
通讯作者:
Vincent A
影响因子:
3.4
作者:
Mors, Ole;Perto, Gurli P.;Mortensen, Preben Bo
通讯作者:
Mortensen, Preben Bo
影响因子:
6.8
作者:
Braunschweig D;Krakowiak P;Duncanson P;Boyce R;Hansen RL;Ashwood P;Hertz-Picciotto I;Pessah IN;Van de Water J
通讯作者:
Van de Water J
DOI:
10.1073/pnas.1216398109
发表时间:
2012-10-30
影响因子:
11.1
作者:
Anderson, Garret R.;Galfin, Timothy;Suedhof, Thomas C.
通讯作者:
Suedhof, Thomas C.
DOI:
10.1093/brain/awq213
发表时间:
2010-09
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Irani SR;Alexander S;Waters P;Kleopa KA;Pettingill P;Zuliani L;Peles E;Buckley C;Lang B;Vincent A
通讯作者:
Vincent A